Supraflex Cruz - Improving patient outcomes: from simple to complex patients
Sponsored by SMT
Coronary Interventions
Multivessel disease
Stable CAD
Stents, scaffolds and DCB
Tools and Technique
SMT
Room 251
Anchorperson: Patrick Serruys
Spokesperson: Faisal Sharif
Discussants: Ignacio J Amat-Santos, Gianluca Campo, Helge Möllmann, Valeria Paradies, Ashok Seth, Joanna Wykrzykowska
Speakers: Simone Biscaglia, Pruthvi Chenniganahosahalli Revaiah, Upendra Kaul, Arpad Lux, Pieter Smits, Azfar G Zaman
Watch this session if you want
- To learn that the treatment spectrum of Supraflex Cruz DES encompasses both simple and complex coronary artery disease (CAD)
- To learn the safety and efficiency of Supraflex Cruz across all patient strata (real world clinical practice; randomised control trials; elderly; high bleeding risk, diabetes)
- To learn the optimal contemporary approach in PCI, encompassing (a) patient selection, (b) physiology to decide on revascularisation, (c) intravascular imaging to optimise PCI and (d) optimal medical therapy, within the ongoing trials addressing 3-vessel disease with and without diabetes mellitus
Session objectives
Faisal Sharif
Performance of Supraflex Cruz in large registries: (1) - UK Registry
Azfar G Zaman
Performance of Supraflex Cruz in large registries: (2) - Dutch Registry
Arpad Lux
Supraflex Cruz use in elderly patient population
Simone Biscaglia
Supraflex Cruz use in patients with high bleeding risk (HBR)
Pieter Smits
Supraflex Cruz use in diabetic patients with multivessel coronary artery disease (CAD)
Upendra Kaul
Contemporary best practice with Supraflex Cruz in patients with three vessel coronary artery disease (CAD)
Pruthvi Chenniganahosahalli Revaiah
Session evaluation and key learnings
Patrick Serruys
Discussion and audience interaction
